Related Experiment Video
Updated: Jul 19, 2025

Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo
Published on: March 8, 2018
Serum MicroRNA-191-5p Levels in Vascular Complications of Type 1 Diabetes: The EURODIAB Prospective Complications
Stefania Bellini1, Simonetta Guarrera2,3, Giuseppe Matullo1,4
1Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
Context:
MicroRNA-191-5p regulates key cellular processes involved in the pathogenesis of diabetic complications such as angiogenesis, extracellular matrix deposition, and inflammation. However, no data on circulating microRNA-191-5p in the chronic complications of diabetes are available.
Objective:
To assess whether serum levels of microRNA-191-5p were associated with micro- and macrovascular disease in a large cohort of subjects with type 1 diabetes mellitus (DM1) from the EURODIAB Prospective Complication Study.
Design And Setting:
Levels of microRNA-191-5p were measured by quantitative PCR in 420 patients with DM1 recruited as part of the cross-sectional analysis of the EURODIAB Prospective Complication Study. Cases (n = 277) were subjects with nephropathy and/or retinopathy and/or cardiovascular disease (CVD). Controls (n = 143) were patients without complications. Logistic regression analysis was performed to evaluate the potential independent association of microRNA-191-5p levels with chronic complications of diabetes.
Results:
Levels of microRNA-191-5p were significantly reduced (P < .001) in cases compared with controls even after adjustment for age, sex, and diabetes duration. Logistic regression analysis revealed that microRNA-191-5p was negatively associated with a 58% reduced odds ratio (OR) of chronic diabetes complications, specifically CVD, micro-macroalbuminuria, and retinopathy (OR, 0.42; 95% CI, 0.23-0.77), independent of age, sex, physical activity, educational levels, diabetes duration, glycated hemoglobin, total insulin dose, hypertension, smoking, total cholesterol, albumin excretion rate, estimated glomerular filtration rate, serum vascular cell adhesion molecule-1, and tumor necrosis factor-α. Analyses performed separately for each complication demonstrated a significant independent association with albuminuria (OR, 0.36; 95% CI, (0.18-0.75) and CVD (OR, 0.34; 95% CI, 0.16-0.70).
Conclusions:
In DM1 subjects, microRNA-191-5p is inversely associated with vascular chronic complications of diabetes.
Insights
Serum levels of microRNA-191-5p were significantly lower in type 1 diabetes patients with chronic vascular complications. Lower microRNA-191-5p levels are independently associated with an increased risk of diabetic complications, including cardiovascular disease and albuminuria.
Area of Science:
- Biochemistry
- Genetics
- Endocrinology
Background:
- MicroRNA-191-5p plays a role in cellular processes relevant to diabetic complications like angiogenesis and inflammation.
- Circulating microRNA-191-5p levels in chronic diabetes complications have not been previously studied.
Purpose of the Study:
- To investigate the association between serum microRNA-191-5p levels and micro- and macrovascular disease in type 1 diabetes mellitus (DM1).
Main Methods:
- Quantitative PCR was used to measure microRNA-191-5p levels in 420 DM1 patients from the EURODIAB Prospective Complication Study.
- Logistic regression analysis was employed to assess the independent association of microRNA-191-5p with diabetes complications, comparing cases (with complications) and controls (without complications).
Main Results:
- MicroRNA-191-5p levels were significantly reduced in DM1 patients with chronic complications compared to controls.
- Reduced microRNA-191-5p was independently associated with a lower odds of developing chronic diabetes complications, including cardiovascular disease, albuminuria, and retinopathy.
Conclusions:
- Serum microRNA-191-5p is inversely associated with vascular chronic complications in type 1 diabetes mellitus.
- Lower levels of microRNA-191-5p may serve as a potential biomarker for predicting the risk of vascular complications in DM1.
More Related Videos
08:21Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
06:48Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment
Published on: April 29, 2022
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications